Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,843 signal articles · 238 in last 24h · 118,416 total before filter · latest 35m ago
238last 24h
1538last 7d
247● bullish (7d)
163● bearish (7d)
205publishers
AllMacro299Earnings623M&A97Regulatory25Product14Analyst23
✕ clear all filtersSentiment:bullishneutralbearishshow all (incl. clickbait)
Lam Research (NASDAQ:LRCX) Reports Q2 In Line With Expectations, Stock Soars
StockStory20d agobullish
Lam Research (NASDAQ:LRCX) Reports Q2 In Line With Expectations, Stock Soars

Semiconductor equipment maker Lam Research (NASDAQ:LRCX) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 30% year on year to $6.72 billion. The company expects next quarter’s revenue to be around $8.1 billion, coming in 13.6% above analysts’ estimates. Its non-GAAP profit of $1.82 per share was 8.1% above analysts’ consensus estimates.

Meta stock falls on Q2 earnings miss: What's next for capex?
Yahoo Finance Video20d agobearishVIDEO
Meta stock falls on Q2 earnings miss: What's next for capex?

Meta (META) reported second quarter results on Wednesday after the closing bell. Earnings per share (EPS) came in at $6.18 (compared to analyst estimates of $7.14), and revenue came in at $60.80 billion (compared to analyst estimates of $60.24 billion). Yahoo Finance Senior Business Reporter Ines Ferré takes a closer look at the breaking numbers.

Peabody Energy Q2 Earnings Call Highlights
MarketBeat20d agoneutral
Peabody Energy Q2 Earnings Call Highlights

Peabody Energy (NYSE:BTU) reported a second-quarter net loss attributable to common stockholders of $90.6 million, or $0.74 per diluted share, and adjusted EBITDA of $24 million, as lower U.S. thermal volumes and elevated commissioning costs at its Centurion metallurgical coal mine weighed on result

Boston Scientific Q2 Earnings Call Highlights
MarketBeat20d agoneutral
Boston Scientific Q2 Earnings Call Highlights

Boston Scientific (NYSE:BSX) reported second-quarter 2026 revenue growth at the high end of its guidance range and adjusted earnings per share above expectations, but lowered its full-year outlook as it faces slowing demand in its WATCHMAN left atrial appendage closure business and increased competi

Aercap Q2 Earnings Call Highlights
MarketBeat20d agoneutral
Aercap Q2 Earnings Call Highlights

Aercap (NYSE:AER) reported second-quarter adjusted earnings of $5.14 per share and raised its full-year 2026 adjusted earnings guidance to approximately $16.80 per share, excluding any additional gains on asset sales in the second half. Chief Executive Officer Aengus Kelly said the aircraft lessor’

Teradyne Q2 Earnings Call Highlights
MarketBeat20d agoneutral
Teradyne Q2 Earnings Call Highlights

Teradyne (NASDAQ:TER) reported record second-quarter revenue of more than $1.3 billion as AI-related demand lifted results across its Semiconductor Test, Product Test and Robotics businesses. Non-GAAP earnings per share reached $2.47, up more than 300% from a year earlier, according to Chief Executi

Visa CEO discloses dynamic investment plan during earnings call
TheStreet20d agoneutral
Visa CEO discloses dynamic investment plan during earnings call

The payment services giant Visa Inc. (NYSE: V) reported the earnings for the fiscal third quarter 2026 on July 28. The company generated $11.6 billion in net revenue and $3.32 in non-GAAP earnings per share (EPS) during the quarter, beating estimates of $11.3 billion revenue and ...